Tazemetostat and Venetoclax in Relapsed/Refractory Non-Hodgkin Lymphoma
Clinical trial NCT05618366 · TERMINATED
Trial details
- NCT number
- NCT05618366
- Sponsor
- Weill Medical College of Cornell University
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-07
- Primary completion
- 2026-02-27
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.